Multimodality therapy in stage III non—small cell lung cancer
- 31 May 1996
- journal article
- review article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 61 (5) , 1564-1572
- https://doi.org/10.1016/0003-4975(96)00044-6
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994
- Surgical treatment for higher stage non-small cell lung cancerThe Annals of Thoracic Surgery, 1992
- Prognostic Significance of Tumor Proliferative Fraction and DNA Content in Stage I Non-Small Cell Lung CancerAmerican Review of Respiratory Disease, 1992
- Relation of neovascularisation to metastasis of non-small-cell lung cancerThe Lancet, 1992
- Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.Journal of Clinical Oncology, 1991
- CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group.Radiology, 1991
- Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features.Journal of Clinical Oncology, 1989
- The Role of Surgery in N2 Lung CancerSurgical Clinics of North America, 1987
- A New International Staging System for Lung CancerChest, 1986
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsThe American Journal of Medicine, 1980